-+ 0.00%
-+ 0.00%
-+ 0.00%

AGOMAB THERAPEUTICS NV - AGMB-447 SHOWS FAVORABLE SAFETY AND TOLERABILITY PROFILE AT 4.5 MG BID IN IPF PATIENTS

Reuters·09/14/2026 20:05:01

Please log in to view news